In this study, nilvadipine can effectively reverse PDE or dexamethasone‐induced 27‐hydroxycholesterol production, TBA and ERS level increases, and adult cholestatic liver injury or hepatocyte injury. The gene discussed is ALDH7A1; the disease is digestive system neoplasm.